OBR Daily Commentary

forumImage

Radiotherapy Offers New Treatment Option for Liver Cancer

(RSNA) Apr 24, 2018 - A novel technique that delivers high doses of radiation to tumors while sparing the surrounding normal tissue shows promise as a curative treatment option for patients with early-stage liver cancer, according to a new study.

Read Article arrow

Howard Sandler, MD, MS, FASTRO (Posted: April 24, 2018)

quotesInteresting experience using focal radiation techniques (with injected radiation) to treat HCC. There are many focal ablative treatments in the liver cancer space including chemoembolization, RFA, cryotherapy, external beam stereotactic radiation approaches. Important for us to improve these techniques as the HCC problem continues to grow! It would be nice to see comparative studies between techniques to help define relative advantages and disadvantages.quotes

Add Comment 1 Comment
forumImage

First Stereotactic Radiation Therapy System Designed To Treat Early Stage Breast Cancer Receives FDA Clearance

(University of Maryland School of Medicine) Dec 22, 2017 - The GammaPod ™ – a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer – has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.

Read Article arrow

Howard Sandler, MD, MS, FASTRO (Posted: January 02, 2018)

quotesInteresting concept and interesting that it made it thru small business grant all the way to FDA 510(k) approval. Now comes the real challenging part: Is there a market for a breast-cancer specific radiation treatment device?quotes

Add Comment 1 Comment
forumImage

PET Scan Identifies Which Prostate Cancer Patients Can Benefit from Salvage Radiation Treatment

(SNMMI) Dec 4, 2017 - For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference.

Read Article arrow

Howard Sandler, MD, MS, FASTRO (Posted: December 05, 2017)

quotesPSMA PET and fluciclovine PET are rapidly changing the management of recurrent prostate cancer. Conventional imaging modalities, say bone scan or CT, would only detect recurrences at relatively high PSA levels when local management might be less optimal. However, PET imaging can now detect low volume, low PSA recurrences after surgery that are potentially amenable to local ablation with additional surgery or radiotherapy.quotes

Add Comment 1 Comment

Meet the Editorial Board

Prostate Cancer
member photo
Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical O...

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Woo...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Pr...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...